Regions Financial Corp’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Regions Financial Corp’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-42	Closed	-$1K	–	1906
2019 Q1	$1K	Hold	42	–	–	﹤0.01%	1910
2018 Q4	$0	Hold	42	–	–	﹤0.01%	2047
2018 Q3	$1K	Hold	42	–	–	﹤0.01%	1946
2018 Q2	$1K	Buy	+42	New	+$901	﹤0.01%	2050

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Regions Financial Corp's MNTA Position: Q2 2019 in Review

Regions Financial Corp sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2019, closing a stake of 42 shares — an estimated $1K sold.

Regions Financial Corp first reported a position in MNTA in Q2 2018 and held it in 4 quarters. The position peaked at $1K in Q1 2019. 155 funds tracked by Wall St. Rank hold MNTA as of Q2 2019.

Regions Financial Corp reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Regions Financial Corp sold 42 Momenta Pharmaceuticals, Inc. shares in Q2 2019, an estimated $1K.
Regions Financial Corp first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2018 and held it in 4 quarters.
Regions Financial Corp's Momenta Pharmaceuticals, Inc. position peaked at $1K in Q1 2019.
155 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2019.

Based on Regions Financial Corp's 13F filing for Q2 2019, filed 19 Jul 2019.